Valuation: Hugel, Inc.

Market Cap 2,010B 1.48B 1.3B 1.23B 1.12B 2.09B 142B 2.11B 14.72B 5.68B 72.43B 5.55B 5.43B 233B P/E 2026 *
13.9x
P/E 2027 * 10.6x
Enterprise Value 1.48B 1.09M 956K 904K 820K 1.54M 104M 1.55M 10.82M 4.17M 53.2M 4.08M 3.99M 171M EV / Sales 2026 *
2.86x
EV / Sales 2027 * 2.09x
Free-Float
45.22%
Yield 2026 *
-
Yield 2027 * -
1 day-0.48%
1 week-13.04%
Current month-26.15%
1 month-24.20%
3 months-26.30%
6 months-28.29%
Current year-19.26%
1 week 182,300
Extreme 182300
205,500
1 month 182,300
Extreme 182300
257,000
Current year 182,300
Extreme 182300
308,500
1 year 182,300
Extreme 182300
308,500
3 years 120,900
Extreme 120900
392,000
5 years 99,700
Extreme 99700
392,000
10 years 75,865.91
Extreme 75865.908
392,000
Manager TitleAgeSince
Director of Finance/CFO 61 -
Chief Tech/Sci/R&D Officer 54 -
Chief Executive Officer 49 -
Director TitleAgeSince
Director/Board Member 54 29/04/2022
Director/Board Member 56 29/04/2022
Director/Board Member 51 29/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
20/05/25 Exercice 1,200 0.0095%
20/05/25 Sell 1,200 0.0095%
19/05/25 Exercice

Chairman

31,510 0.2500%
Change 5-day change 1-year change 3-year change Capi.($)
-0.48%-13.04%-36.81%+48.88% 1.49B
-0.80%+28.07%+705.55%+98.39% 79.4B
-4.54%-4.15%+33.40%-9.65% 78.69B
+2.80%+3.60%-6.34%-27.82% 59.52B
-0.89%+2.11%+7.92%+170.43% 46.58B
+2.49%+0.14%-8.95%+33.71% 46.53B
+0.48%+6.12%+66.48%-11.20% 33.63B
+0.75%-0.39%+50.93%+111.17% 25.11B
-3.56%-0.47%+3.11%+135.37% 22.13B
+0.73%-1.70%+61.19%+100.64% 15.31B
Average -0.21%+2.57%+87.65%+64.99% 40.84B
Weighted average by Cap. -0.34%+6.64%+153.51%+53.70%

Financials

2026 *2027 *
Net sales 516B 380M 334M 316M 287M 538M 36.44B 541M 3.78B 1.46B 18.6B 1.43B 1.39B 59.94B 642B 472M 416M 393M 356M 669M 45.33B 673M 4.7B 1.82B 23.14B 1.77B 1.73B 74.55B
Net income 162B 119M 105M 99.4M 90.14M 169M 11.46B 170M 1.19B 459M 5.85B 448M 439M 18.85B 212B 156M 137M 130M 118M 221M 14.99B 223M 1.56B 600M 7.65B 586M 574M 24.65B
Net Debt -534B -392M -345M -327M -296M -556M -37.66B -559M -3.91B -1.51B -19.22B -1.47B -1.44B -61.94B -665B -489M -430M -407M -369M -693M -46.94B -697M -4.87B -1.88B -23.96B -1.84B -1.8B -77.2B
Logo Hugel, Inc.
Hugel Inc is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceutical products. The Company is mainly engaged in the research, development, manufacturing, and sales of biopharmaceuticals utilizing type A botulinum toxin derived from the microorganism clostridium botulinum, as well as hyaluronic acid–based tissue‑restoration biomaterial filler products. In addition, the Company sells botulinum toxin products, hyaluronic acid fillers, cosmetics, skin boosters, and lifting threads. The Company distributes its products in domestic and overseas markets.
Employees
620
Date Price Change Volume
28/09/26 ₩186,100.00 -0.48% 85,822
23/09/26 ₩187,000.00 -1.79% 42,222
22/09/26 ₩190,400.00 -7.57% 204,511
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
186,100.00KRW
Average target price
345,823.53KRW
Spread / Average Target
+85.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A145020 Stock